Indication
Autosomal Recessive Hypophosphatemic Rickets Type 2
1 clinical trial
1 product
Clinical trial
The ADAPT Study: An Open-label, Long-term Safety Study of INZ-701 in Patients With ENPP1 Deficiency and ABCC6 DeficiencyStatus: Not yet recruiting, Estimated PCD: 2030-11-01
Product
INZ-701